Dalpicilib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Dalpicilib, covering 2023-02-10 to 2025-07-18. Get the full timeline:
Most recent: Clinical Trial Update: Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC [Phase 2]